U.S. Machinery Stock News

NasdaqGM:ZLAB
NasdaqGM:ZLABBiotechs

Is Zai Lab (ZLAB) Resetting After Multi‑Year Share Price Declines?

If you are wondering whether Zai Lab's current share price reflects its real worth, you are not alone. This article walks through what the numbers suggest about value. The stock last closed at US$20.03, with returns of 11.3% over 7 days, 2.1% over 30 days, 15.6% year to date, but a 30.9% decline over 1 year, 46.4% over 3 years and 88.6% over 5 years. These mixed returns sit against a backdrop where investors have been watching Zai Lab as part of the broader pharmaceuticals and biotech space,...
NYSE:ITT
NYSE:ITTMachinery

How ITT’s (ITT) Q4 Results, Buybacks and Double-Digit Q1 Outlook Have Changed Its Investment Story

In early February 2026, ITT Inc. reported fourth-quarter 2025 sales of US$1,054 million and net income of US$131.7 million, alongside a completed US$549.88 million share repurchase program and a declared quarterly dividend of US$0.3860 per share. At the same time, ITT issued first-quarter 2026 guidance calling for roughly 11% revenue growth and earnings per share of US$1.67 to US$1.71, underscoring management’s confidence following strong order momentum and acquisition integration. With ITT...
NasdaqGS:ICLR
NasdaqGS:ICLRLife Sciences

Is ICON (ICLR) Offering An Opportunity After The Recent 50% Share Price Slide

If you are wondering whether ICON's current share price still reflects its underlying value, you are not alone. This article is built to help you connect the stock price to what the business may be worth. ICON's share price closed at US$93.00, with returns of a 38.2% decline over 7 days, a 49.7% decline over 30 days, a 50.7% decline year to date, a 50.1% decline over 1 year, a 59.1% decline over 3 years, and a 55.3% decline over 5 years, which may have changed how some investors think about...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna (MRNA) Quarterly Loss Narrows To US$200 Million Challenging Bearish Profitability Narratives

How Moderna's Latest Numbers Set the Stage for Its Next Chapter Moderna (MRNA) has just posted third quarter FY 2025 revenue of US$1,016 million with a basic EPS loss of US$0.51 and net income loss of US$200 million, as its mRNA platform continues to move through an investment heavy phase. The company has seen quarterly revenue move from US$966 million in Q4 2024 to US$108 million in Q1 2025, US$142 million in Q2 2025 and then US$1,016 million in Q3 2025. Over the same stretch, basic EPS...
NYSE:MANU
NYSE:MANUEntertainment

Assessing Manchester United (NYSE:MANU) Valuation After Recent Share Price Momentum

Why Manchester United (NYSE:MANU) is on investors’ radar now Manchester United (NYSE:MANU) has drawn fresh attention after a stretch of mixed share performance, with modest gains over the past week, month and past 3 months prompting investors to reassess how the club’s business metrics line up with its current valuation. See our latest analysis for Manchester United. At a share price of $17.44, Manchester United’s recent momentum is more visible over the past quarter, with an 11.3% 90 day...
NYSE:G
NYSE:GProfessional Services

Is Genpact (G) Now A Potential Opportunity After A 31% One-Year Share Price Decline

If you are wondering whether Genpact is starting to look like value at the current share price, this article walks through what the numbers actually say. The stock closed at US$37.36, with returns of a 7.5% decline over 7 days, 21.2% decline over 30 days, 18.6% decline year to date and 31.1% decline over 1 year, while the 5-year return sits around 0.6%. Recent coverage of business process outsourcing and digital operations providers has focused on how companies like Genpact are positioned...
OTCPK:FMCC
OTCPK:FMCCDiversified Financial

Freddie Mac (OTCPK:FMCC) Narrows Quarterly Losses Challenging Persistent Bearish Narratives On Profitability

Federal Home Loan Mortgage (FMCC) FY 2025 earnings snapshot Federal Home Loan Mortgage (FMCC) has wrapped up FY 2025 with fourth quarter revenue of US$5.7 billion, a basic EPS loss of US$0.002 per share and net income excluding extra items showing a loss of US$7 million, against prior year fourth quarter revenue of US$6.2 billion, basic EPS of US$0.011 per share and net income of US$37 million. Over the past few quarters, revenue has ranged from US$5.1 billion to US$5.7 billion in FY 2025,...
NYSE:TMHC
NYSE:TMHCConsumer Durables

Is Taylor Morrison (TMHC) Still Attractive After Recent Gains And Housing Sector Headlines

If you are wondering whether Taylor Morrison Home is still good value at around US$68.86, you are not alone. A closer look at its valuation tools can help you frame that question clearly. The stock last closed at US$68.86, with returns of 5.6% over 7 days, 8.5% over the past month, 17.0% year to date, 7.3% over 1 year, 92.1% over 3 years and 140.7% over 5 years. This gives useful context before comparing price to underlying value. Recent news coverage around Taylor Morrison Home has focused...
NasdaqGS:IMKT.A
NasdaqGS:IMKT.AConsumer Retailing

A Look At Ingles Markets (IMKT.A) Valuation After Strong First Quarter Earnings Release

Ingles Markets (IMKT.A) is back in focus after its latest earnings release, with first quarter sales of US$1,372.98 million and net income of US$28.13 million, both higher than the prior year’s figures. See our latest analysis for Ingles Markets. The earnings release appears to have reset expectations. The 30 day share price return of 28.25% and the year to date share price return of 28.23% point to stronger near term momentum. The 1 year total shareholder return of 37.60% contrasts with a...
NYSE:FHN
NYSE:FHNBanks

First Horizon’s New CISO Appointment And What It Means For Investors

First Horizon (NYSE:FHN) has appointed Leilani Farol as Senior Vice President and Chief Information Security Officer. Farol will lead the bank's enterprise cybersecurity strategy and data protection efforts. For you as an investor, this move highlights how seriously First Horizon is treating cybersecurity at a time when digital risks are front and center for financial institutions. The company’s shares last closed at $24.56, with a 1 year return of 14.4% and a 5 year return of 78.3%, which...
NYSE:NSP
NYSE:NSPProfessional Services

Insperity Cost Cuts And HRScale Rollout Test Valuation Gap

Insperity (NYSE:NSP) is rolling out major cost-cutting measures, including a reduction in non-sales staff and tighter expense controls, in response to profitability pressure. The company is targeting a $20 million cut in operating expenses while pushing ahead with HRScale, its new mid-market HR platform developed with Workday. HRScale is aimed at thousands of employees across small and mid-sized businesses, signaling a shift in how Insperity serves the mid-market HR segment. For investors...
NasdaqGS:PPC
NasdaqGS:PPCFood

Pilgrim's Pride Growth Plans Test Valuation And Earnings Outlook

Pilgrim's Pride is expanding its Just Bare brand and planning new growth projects as it responds to current industry conditions. The company is preparing investments in a new Georgia facility and increasing capital deployment in Mexico. These moves come while Pilgrim's Pride manages challenges such as commodity price swings and pressure on margins. Pilgrim's Pride, traded as NasdaqGS:PPC, is pushing ahead with brand and capacity expansion while its shares trade around $43.32. Over the past...
NYSE:GWW
NYSE:GWWTrade Distributors

Why W.W. Grainger (GWW) Is Down 5.5% After Mixed 2025 Results, 2026 Guidance And New Lawsuit

W.W. Grainger, Inc. recently reported past fourth-quarter 2025 results showing sales of US$4,425 million and full-year 2025 sales of US$17.94 billion, alongside issuing 2026 net sales guidance of US$18.70 billion to US$19.10 billion while also facing a new California labor class action alleging wage and hour violations. Despite higher sales, the company’s 2025 net income and earnings per share from continuing operations declined, highlighting pressure on profitability as it invests in...
NYSE:AJG
NYSE:AJGInsurance

Can Gallagher (AJG) Defend Its Brokerage Moat As AI Tools Challenge Traditional Intermediaries?

In early February 2026, Gallagher Re appointed Minesh Jani, a reinsurance veteran with over three decades of experience and most recently Managing Director of Howden Insurance Brokers’ DIFC branch, as CEO for its India operations. Around the same time, OpenAI’s launch of insurance-native AI tools sparked sector-wide discussion about how far artificial intelligence could displace traditional insurance brokers’ role in matching clients with coverage. We’ll now examine how investor concerns...
NYSE:PFGC
NYSE:PFGCConsumer Retailing

Assessing Performance Food Group’s Valuation After Profit Miss And Ongoing Integration Headwinds

Quarterly miss, integration costs and deflation in focus Performance Food Group (PFGC) recently reported quarterly results where profit fell short of market expectations as Cheney Brothers integration costs and deflation in categories like cheese and poultry pressured margins, even as revenue continued to grow. Management reaffirmed revenue guidance for the upcoming quarter and maintained a positive longer term growth outlook. Analysts noted that higher operating expenses and acquisition...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

Protagonist Therapeutics Milestones Test Valuation As NDAs And Trials Advance

Protagonist Therapeutics submitted NDAs for Icotrokinra in plaque psoriasis and Rusfertide in polycythemia vera, advancing two late stage drug candidates. The company is progressing Phase 3 trials in partnership with large pharmaceutical companies, including Johnson & Johnson and Takeda. These filings and trial advances represent fresh milestones for NasdaqGM:PTGX that have not yet been widely discussed in the market. Protagonist Therapeutics, trading on NasdaqGM:PTGX, is drawing fresh...
NasdaqGS:PAA
NasdaqGS:PAAOil and Gas

Is Plains All American Pipeline (PAA) Pricing Reflective Of Its Strong Multi‑Year Share Recovery?

If you are looking at Plains All American Pipeline and wondering whether the current price reflects its true worth, this article will help you frame that value question clearly. The stock last closed at US$20.15, with returns of 3.9% over 7 days, 5.7% over 30 days, 10.7% year to date, 11.0% over 1 year and a very large gain over 5 years that points to a big shift in how the market has treated the company over time. Recent coverage around Plains All American Pipeline has focused on its role...
NasdaqGS:ROKU
NasdaqGS:ROKUEntertainment

Roku (ROKU) Profit Swing To US$0.54 Q4 EPS Tests Long Term Bearish Narratives

Roku’s FY 2025 results reset the profit story Roku (ROKU) closed out FY 2025 with Q4 revenue of about US$1.4 billion and basic EPS of US$0.54, capping a year in which trailing twelve month revenue reached roughly US$4.7 billion and EPS landed at US$0.60. The company has seen quarterly revenue move from US$1.20 billion in Q4 2024 to US$1.39 billion in Q4 2025, while basic EPS shifted from a loss of US$0.24 to a profit of US$0.54. This gives investors a clearer view of how margins are now...
NasdaqGS:CINF
NasdaqGS:CINFInsurance

Cincinnati Financial (CINF) Is Down 5.7% After Resilient Q4 Earnings And Record Cat Losses - What's Changed

Cincinnati Financial Corporation recently reported fourth-quarter 2025 results, with revenue rising to US$3,091 million and net income to US$676 million, while basic earnings per share from continuing operations increased to US$4.34 from US$2.59 a year earlier. Beyond the headline beats, the insurer renewed key reinsurance treaties on improved terms and achieved underwriting profit despite experiencing the largest catastrophe loss in its history, underscoring the resilience of its business...
NYSE:LDOS
NYSE:LDOSProfessional Services

Leidos Deepens Role In Defense AI Security And Long Term IT Programs

Leidos Holdings (NYSE:LDOS) is accelerating migrations of Defense Agencies to DODNet as part of the multi billion dollar Defense Enclave Services program. The company secured a federal contract to deliver integrated AI and Zero Trust security solutions for critical defense networks. Leidos announced new partnerships with RegScale and Trustible to automate cybersecurity compliance, continuous monitoring, and AI risk management for federal agencies. For investors watching defense IT...
NasdaqGS:CVRX
NasdaqGS:CVRXMedical Equipment

CVRx (CVRX) Q3 Loss Near US$12.9 Million Reinforces Profitability Concerns Despite Growth Narratives

Setting the scene on CVRx's latest results CVRx (CVRX) has reported third quarter FY 2025 revenue of US$14.7 million with a basic EPS loss of US$0.49, alongside trailing twelve month revenue of US$56.0 million and a basic EPS loss of US$2.02, giving investors a clear view of a company still in investment mode. The company has seen quarterly revenue move from US$11.8 million in Q2 2024 to US$14.7 million in Q3 2025. Quarterly basic EPS losses have ranged between US$0.43 and US$0.65 over the...
NYSE:NEU
NYSE:NEUChemicals

Has The Recent Share Price Slide Opened An Opportunity In NewMarket (NEU)?

Are you wondering if NewMarket's current share price reflects its real worth, or if the recent moves have opened up a mispricing you could potentially take advantage of? The stock last closed at US$592.80, after an 18.1% decline over the past week and a 16.4% decline over the past month. This comes even though the 1 year, 3 year and 5 year returns sit at 11.1%, 82.1% and 67.3% respectively. Recent attention on NewMarket has focused on its role in the materials sector and how investors are...
NasdaqGS:RIVN
NasdaqGS:RIVNAuto

Rivian Automotive (RIVN) Earnings Highlight Persistent US$811 Million Q4 Loss Challenging Bullish Narratives

Rivian Automotive (RIVN) just closed out FY 2025 with fourth quarter revenue of US$1.3 billion, a basic EPS loss of US$0.66, and net income loss of US$811 million, setting the tone for how investors will read the full year. Over the past six quarters, revenue has moved between US$874 million in Q3 2024 and US$1.7 billion in Q4 2024, while quarterly basic EPS has ranged from a loss of US$0.48 in Q1 2025 to a loss of US$1.08 in Q3 2024. This highlights a business that is scaling the top line...
NasdaqGS:MLKN
NasdaqGS:MLKNCommercial Services

Is It Too Late To Consider MillerKnoll (MLKN) After Recent Share Price Rebound

If you are wondering whether MillerKnoll at around US$21.78 still offers value or if the easy gains are gone, this article will explain what the current price reflects in more detail. The stock has shown a mixed pattern, with a 13.2% return over the last 30 days and 19.3% year to date, but a 3.4% decline over the past week and a 32.0% decline over five years that some investors may still have in mind. Recent coverage has focused on how MillerKnoll fits into the commercial services and office...